ArticleMedicine2026
Analysis of the current situation and influencing factors of dyslipidemia among adults in Guangzhou based on a cross-sectional survey.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to understand the epidemiological characteristics of dyslipidemia by analyzing the data of adult chronic disease and risk factor surveillance in Guangzhou in 2018, as well as to investigate the common dyslipidemia combination and its influencing factors in Guangzhou and provide theoretical support for the prevention and control of dyslipidemia. Data were collected using a combination of centralized and household surveys. The Rao-Scott χ2 test was employed to compare dyslipidemia prevalence among populations with different characteristics. Multivariate analysis using binary logistic regression was conducted to identify factors associated with dyslipidemia. In 2018, the overall prevalence of dyslipidemia among adults in Guangzhou City was 37.6%. Being female (odds ratio [OR] = 0.509), meeting physical activity guidelines (OR = 0.844), and never smoking (OR = 0.801) were protective factors against dyslipidemia. Increasing age (OR > 1.5) was a risk factor for dyslipidemia, with the OR values showing an initial increase followed by a decreasing trend with advancing age. Overweight (OR = 1.952) or obesity (OR = 3.389), abnormal blood glucose (OR = 1.365), and hypertension (OR = 1.238) were also significant risk factors for dyslipidemia. Among single lipid abnormalities, high total triglycerides (High TG) had the highest prevalence rate. The most common dual lipid abnormality combination was high low-density lipoprotein cholesterol + High TG, with a prevalence rate of 10.2%. The combination of high low-density lipoprotein cholesterol + high total cholesterol + High TG was the most prevalent triple abnormality. The prevalence of dyslipidemia among adults in Guangzhou City in 2018 was concerning. Continuous efforts are needed to enhance health education on dyslipidemia, increase awareness, and improve control rates. Simultaneous efforts should be made to prevent and manage diabetes and hypertension among the population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.